Quick Takeaways
- YA II PN, Ltd. filed SCHEDULE 13G for InMed Pharmaceuticals Inc. Common Shares (INM).
- Disclosed ownership: 10%.
- Date of event: 13 Dec 2024.
YA II PN, Ltd. - 13 Dec 2024 SCHEDULE 13G Report for InMed Pharmaceuticals Inc. Common Shares (INM)
- Filing Manager
- YA II PN, Ltd.
- Reporting Manager
- YA II PN, Ltd.
- Symbol
- INM
- Shares outstanding
- 804,525 shares
- Disclosed Ownership
- 80,372 shares
- Ownership
- 10%
- Form type
- SCHEDULE 13G
- Filing time
- 18 Dec 2024, 08:05:00 UTC
- Date of event
- 13 Dec 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"YA II PN, Ltd. disclosed 10% ownership in InMed Pharmaceuticals Inc. Common Shares (INM) on 13 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 18 Dec 2024, 08:05.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (8)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| YA II PN, Ltd. | 10% | 80,372 | 0 | 80,372 | /s/ David Gonzalez | David Gonzalez, General Counsel | |
| YA Global Investments II (U.S.), LP | 10% | 80,372 | 0 | 80,372 | /s/ David Gonzalez | David Gonzalez, General Counsel | |
| Yorkville Advisors Global, LP | 10% | 80,372 | 0 | 80,372 | /s/ David Gonzalez | David Gonzalez, General Counsel | |
| Yorkville Advisors Global II, LLC | 10% | 80,372 | 0 | 80,372 | /s/ David Gonzalez | David Gonzalez, General Counsel | |
| YA II GP, LP | 10% | 80,372 | 0 | 80,372 | /s/ David Gonzalez | David Gonzalez, General Counsel | |
| YAII GP II, LLC | 10% | 80,372 | 0 | 80,372 | /s/ David Gonzalez | David Gonzalez, General Counsel | |
| Mark Angelo | 10% | 80,372 | 0 | 80,372 | /s/ Mark Angelo | Mark Angelo | |
| SC-Sigma Global Partners, LP | 10% | 80,372 | 0 | 80,372 | /s/ David Gonzalez | David Gonzalez, General Counsel |